Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy.

Abu Eid R.

Front Oncol. 2019 Mar 19;9:172. doi: 10.3389/fonc.2019.00172. eCollection 2019. No abstract available.

2.

Deciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review.

O'Higgins C, Ward FJ, Abu Eid R.

Front Oncol. 2018 Oct 15;8:442. doi: 10.3389/fonc.2018.00442. eCollection 2018.

3.

On the Road to Immunotherapy-Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies.

Ward FJ, Dahal LN, Abu-Eid R.

Front Immunol. 2018 Sep 24;9:2182. doi: 10.3389/fimmu.2018.02182. eCollection 2018. Review.

4.

Antigen-Specific Antitumor Responses Induced by OX40 Agonist Are Enhanced by the IDO Inhibitor Indoximod.

Berrong Z, Mkrtichyan M, Ahmad S, Webb M, Mohamed E, Okoev G, Matevosyan A, Shrimali R, Abu Eid R, Hammond S, Janik JE, Khleif SN.

Cancer Immunol Res. 2018 Feb;6(2):201-208. doi: 10.1158/2326-6066.CIR-17-0223. Epub 2018 Jan 5.

5.

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition.

Abu Eid R, Ahmad S, Lin Y, Webb M, Berrong Z, Shrimali R, Kumai T, Ananth S, Rodriguez PC, Celis E, Janik J, Mkrtichyan M, Khleif SN.

Cancer Res. 2017 Aug 1;77(15):4135-4145. doi: 10.1158/0008-5472.CAN-16-1925. Epub 2017 Jun 14.

6.

Oligohydramnios compromises lung cells size and interferes with epithelial-endothelial development.

Najrana T, Ramos LM, Abu Eid R, Sanchez-Esteban J.

Pediatr Pulmonol. 2017 Jun;52(6):746-756. doi: 10.1002/ppul.23662. Epub 2017 Feb 2.

PMID:
28152278
7.

Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy.

Ahmad S, Abu-Eid R, Shrimali R, Webb M, Verma V, Doroodchi A, Berrong Z, Samara R, Rodriguez PC, Mkrtichyan M, Khleif SN.

Cancer Res. 2017 Apr 15;77(8):1892-1904. doi: 10.1158/0008-5472.CAN-16-1839. Epub 2017 Jan 20.

8.

Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed.

Abu Eid R, Razavi GS, Mkrtichyan M, Janik J, Khleif SN.

Cancer Immunol Res. 2016 May;4(5):377-82. doi: 10.1158/2326-6066.CIR-16-0048. Epub 2016 May 1. Review.

9.

Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells.

Zdanov S, Mandapathil M, Abu Eid R, Adamson-Fadeyi S, Wilson W, Qian J, Carnie A, Tarasova N, Mkrtichyan M, Berzofsky JA, Whiteside TL, Khleif SN.

Cancer Immunol Res. 2016 Apr;4(4):354-65. doi: 10.1158/2326-6066.CIR-15-0241. Epub 2016 Feb 15.

10.

Programmed death-1 & its ligands: promising targets for cancer immunotherapy.

Shrimali RK, Janik JE, Abu-Eid R, Mkrtichyan M, Khleif SN.

Immunotherapy. 2015;7(7):777-92. doi: 10.2217/imt.15.49. Epub 2015 Aug 7. Review.

PMID:
26250412
11.

Full Mouth Implant-supported Rehabilitation of a Patient with Ectodermal Dysplasia: Clinical Report and Literature Review.

Kutkut A, Abu-Eid R, Sharab L, Abadi B, Van Sickels J.

J Int Acad Periodontol. 2015 Apr;17(2):34-41. Review.

PMID:
26242009
12.

Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival.

Abu Eid R, Friedman KM, Mkrtichyan M, Walens A, King W, Janik J, Khleif SN.

Oncoimmunology. 2015 Feb 3;4(5):e1005448. eCollection 2015 May.

13.

Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer.

Rahma OE, Herrin VE, Ibrahim RA, Toubaji A, Bernstein S, Dakheel O, Steinberg SM, Abu Eid R, Mkrtichyan M, Berzofsky JA, Khleif SN.

J Transl Med. 2014 Dec 16;12:353. doi: 10.1186/s12967-014-0353-4.

14.

Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

Abu-Eid R, Samara RN, Ozbun L, Abdalla MY, Berzofsky JA, Friedman KM, Mkrtichyan M, Khleif SN.

Cancer Immunol Res. 2014 Nov;2(11):1080-9. doi: 10.1158/2326-6066.CIR-14-0095. Epub 2014 Jul 30.

15.
16.

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy.

Mkrtichyan M, Chong N, Abu Eid R, Wallecha A, Singh R, Rothman J, Khleif SN.

J Immunother Cancer. 2013 Aug 29;1:15. doi: 10.1186/2051-1426-1-15. eCollection 2013.

17.

Dentistry a second time?

Oweis Y, Hattar S, Abu Eid R, Sabra A.

Eur J Dent Educ. 2012 Feb;16(1):e10-8. doi: 10.1111/j.1600-0579.2010.00666.x. Epub 2010 Dec 29. Erratum in: Eur J Dent Educ. 2012 May;16(2):118. Eid, R A [corrected to Abu Eid, R].

PMID:
22251331
18.

Age and the architecture of oral mucosa.

Abu Eid R, Sawair F, Landini G, Saku T.

Age (Dordr). 2012 Jun;34(3):651-8. doi: 10.1007/s11357-011-9261-1. Epub 2011 May 11.

19.

Assessment of self-medication of antibiotics in a Jordanian population.

Sawair FA, Baqain ZH, Abu Karaky A, Abu Eid R.

Med Princ Pract. 2009;18(1):21-5. doi: 10.1159/000163041. Epub 2008 Dec 4.

20.
21.

Morphometry of pseudoepitheliomatous hyperplasia: objective comparison to normal and dysplastic oral mucosae.

Abu Eid R, Landini G.

Anal Quant Cytol Histol. 2005 Aug;27(4):232-40.

PMID:
16220835
22.

Quantification of the global and local complexity of the epithelial-connective tissue interface of normal, dysplastic, and neoplastic oral mucosae using digital imaging.

Abu Eid R, Landini G.

Pathol Res Pract. 2003;199(7):475-82. Erratum in: Pathol Res Pract. 2003;199(10):703-4.

PMID:
14521264

Supplemental Content

Loading ...
Support Center